Research Article
Prognostic Value of Rab27B Nuclear Expression in Gastrointestinal Stromal Tumors
Table 2
Univariate and multivariate analysis of prognostic factors in GIST for 5-year survival.
| | Univariate analysis | Multivariate analysis | HR | | 95% CI | HR | | 95% CI |
| Rab27B expression | | | | | | | | | High versus low | 2.61 | 0.009* | 1.384 | 9.843 | 2.07 | 0.038* | 1.070 | 10.925 | Gender | | | | | | | | | Male versus female | −1.52 | 0.128 | .250 | 1.191 | | | | | Age (years) | | | | | | | | | ≤60 versus >60 | 0.32 | 0.746 | .531 | 2.423 | | | | | Tumor diameter (cm) | | | | | | | | | <5 versus 5–10 versus ≥10 | 2.57 | 0.010* | 1.202 | 3.894 | | | | | Mitotic index (per 50 HPFs) | | | | | | | | | 0–5 versus 6–10 versus >10 | 4.37 | <0.001* | 1.885 | 5.287 | 2.18 | 0.029* | 1.236 | 50.063 | Gross classification | | | | | | | | | Single versus multiple | 0.47 | 0.639 | .337 | 5.904 | | | | | Tumor position | | | | | | | | | Stomach versus intestine versus others | 0.28 | 0.782 | .629 | 1.850 | | | | | AFIP Miettinen risk classification | | | | | | | | | Very low-low risk versus moderate-high risk | 1.97 | 0.049* | 1.003 | 8.178 | | | | | Tumor grade | | | | | | | | | Stages I-II versus Stages III-IV | 4.18 | <0.001* | 1.560 | 3.415 | | | | |
|
|
.
|